CIK: 0001534261 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 14, 2018
Total Value ($000): $822,765 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | LOXO ONCOLOGY INC | 360,000 | $61,499 | 7.5% | $28.44 | — | COM | 548862101 |
| — | BLUEPRINT MEDICINES CORP | 750,000 | $58,545 | 7.1% | $53.83 | — | COM | 09627Y109 |
| — | MYOKARDIA INC | 805,000 | $52,486 | 6.4% | $30.98 | — | COM | 62857M105 |
| AGIO | AGIOS PHARMACEUTICALS INC | 579,776 | $44,712 | 5.4% | $66.22 | +21.5% | COM | 00847X104 |
| — | SAGE THERAPEUTICS INC | 312,000 | $44,070 | 5.4% | $70.16 | — | COM | 78667J108 |
| BLFS | BIOLIFE SOLUTIONS INC | 2,428,571 | $42,500 | 5.2% | $15.38 | +28.6% | COM NEW | 09062W204 |
| FATE | FATE THERAPEUTICS INC | 2,550,000 | $41,540 | 5.0% | $4.33 | +173.2% | COM | 31189P102 |
| — | INVITAE CORP | 2,400,000 | $40,152 | 4.9% | $16.73 | — | COM | 46185L103 |
| — | BLUEBIRD BIO INC | 258,000 | $37,668 | 4.6% | $130.95 | — | COM | 09609G100 |
| — | SPARK THERAPEUTICS INC | 675,000 | $36,821 | 4.5% | $57.42 | — | COM | 84652J103 |
| CDXS | CODEXIS INC | 2,025,000 | $34,729 | 4.2% | $5.90 | +173.6% | COM | 192005106 |
| SGMO | SANGAMO THERAPEUTICS INC | 2,000,000 | $33,900 | 4.1% | $8.03 | +89.3% | COM | 800677106 |
| — | MAGENTA THERAPEUTICS INC | 2,250,818 | $27,032 | 3.3% | $13.36 | — | COM | 55910K108 |
| ILMN | ILLUMINA INC | 71,500 | $26,245 | 3.2% | $196.93 | +62.7% | COM | 452327109 |
| — | GENMARK DIAGNOSTICS INC | 3,500,000 | $25,725 | 3.1% | $6.86 | — | COM | 372309104 |
| — | AUDENTES THERAPEUTICS INC | 625,000 | $24,744 | 3.0% | $24.86 | — | COM | 05070R104 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 270,000 | $23,630 | 2.9% | $85.55 | +17.6% | COM | 02043Q107 |
| VYGR | VOYAGER THERAPEUTICS INC | 1,135,000 | $21,474 | 2.6% | $14.86 | — | COM | 92915B106 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 440,000 | $16,720 | 2.0% | $32.45 | — | COM | 37890U108 |
| EVH | EVOLENT HEALTH INC | 550,000 | $15,620 | 1.9% | $17.59 | +35.6% | CL A | 30050B101 |
| EDIT | EDITAS MEDICINE INC | 460,000 | $14,637 | 1.8% | $29.22 | +10.6% | COM | 28106W103 |
| ONC | BEIGENE LTD | 70,000 | $12,055 | 1.5% | $149.93 | — | SPONSORED ADR | 07725L102 |
| — | GRITSTONE ONCOLOGY INC | 720,586 | $10,261 | 1.2% | $14.24 | — | COM | 39868T105 |
| CRSP | CRISPR THERAPEUTICS AG | 220,000 | $9,757 | 1.2% | $47.34 | +10.6% | NAMEN AKT | H17182108 |
| — | CONSTELLATION PHARMCETICLS I | 1,314,743 | $8,848 | 1.1% | $6.73 | — | COM | 210373106 |
| OSUR | ORASURE TECHNOLOGIES INC | 525,000 | $8,111 | 1.0% | $17.66 | -7.2% | COM | 68554V108 |
| — | HOMOLOGY MEDICINES INC | 350,000 | $8,001 | 1.0% | $21.76 | — | COM | 438083107 |
| — | CLOVIS ONCOLOGY INC | 235,000 | $6,902 | 0.8% | $69.25 | — | COM | 189464100 |
| SRPT | SAREPTA THERAPEUTICS INC | 40,000 | $6,460 | 0.8% | $136.70 | 0.0% | COM | 803607100 |
| CDNA | CAREDX INC | 200,000 | $5,770 | 0.7% | $11.47 | +63.2% | COM | 14167L103 |
| NEOG | NEOGEN CORP | 65,000 | $4,649 | 0.6% | $30.13 | +41.5% | COM | 640491106 |
| — | CELGENE CORP | 50,000 | $4,475 | 0.5% | — | — | Call | 151020104 |
| GILD | GILEAD SCIENCES INC | 50,000 | $3,861 | 0.5% | — | — | Call | 375558103 |
| CTMX | CYTOMX THERAPEUTICS INC | 207,500 | $3,839 | 0.5% | $17.02 | +33.9% | COM | 23284F105 |
| — | NEON THERAPEUTICS INC | 338,345 | $2,889 | 0.4% | $12.60 | — | COM | 64050Y100 |
| — | JOUNCE THERAPEUTICS INC | 375,000 | $2,438 | 0.3% | $18.19 | — | COM | 481116101 |